PQ Program Evaluation — Pilot RCT

Protocol 2026P000564 · Slavin Academy funded ·
Johanna Lee — PI / first author Jimin Kim — BWH site PI Dan S-K — senior author

What's due when

Countdowns update each time you open this page

Timeline (Gantt)

May'26
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Jan'27
Feb
Mar
Apr
May
Jun
Jul
IRB expedited review
Engage RA + ARC1h
Acceptability instrument0.5h
MyCAP: instruments5h
MyCAP: control + triggers25h
Recruitment materials2h
Manuscript outline4h
Pilot-test MyCAP5h
Recruitment ramp4h
6-wk program + T0/T1
Analysis → draft → submit64h
Milestones
Pre-launch build ≈ 54h total · ~30h (MyCAP instruments + control build) offloadable to the research assistant → PI-level lift ≈ 24h spread across June–Sept.
Active Pending Milestone Slavin report Today

Study at a glance

PGY4 residents · MGH + BWH n ≤ 57 · optional loved-one dyad Baseline T0 SCS-SF · MBI-GS · PHQ-8 · GAD-7 Randomize 1:1 (by site) PQ program 6 wk · weekly video + daily reps Active control 6 wk · MyCap, time-matched Post T1 (~wk 8–12) Same 4 measures + feasibility / acceptability Unblinded · 1:1 · stratified by site · ~12 wk per participant
QuestionIs a 6-wk app-based mental-fitness program feasible & acceptable in anesthesiology residents, and what effect sizes does it produce?
DesignPilot RCT, 2-arm parallel, 1:1, multi-site, unblinded
ComparatorActive control (MyCap), matched for time + attention
Remuneration$40 (T0) + $60 (T1) = $100; lifetime PQ access
TargetJEPM original article (3000 words, 30 refs); present at SEA
PurposeFeasibility + effect-size data to power a future multi-site efficacy trial

Outcomes & measures

Primary Feasibility
OutcomeSpecific measure
Recruitment rate% of eligible PGY4 residents who consent
Dyadic enrollment rate% of consenting residents who enroll a loved one
Retention rate% of enrolled who complete the T1 assessment
AdherenceModule completion + daily engagement, from app/platform backend
Primary Acceptability, appropriateness & feasibility recommended set
Replaces the draft items (which mixed acceptability with perceived efficacy) with the validated Weiner et al. triad: three 4-item scales, each rated 1 (completely disagree) – 5 (completely agree), administered at T1 for both arms. Keeps acceptability cleanly separable from the efficacy signal and is instantly interpretable to reviewers.
Measure (4 items, 5-pt)Item stems — "The PQ program…"
AIM — Acceptability…meets my approval · is appealing to me · I like it · I welcome it
IAM — Appropriateness…seems fitting · seems suitable · seems applicable · seems like a good match
FIM — Feasibility…seems implementable · seems possible · seems doable · seems easy to use
NPS (retained)"How likely are you to recommend this program to a colleague or fellow resident?" (0–10)
Open-ended (retained)Most beneficial? · Suggested improvements? · Single biggest barrier to completion?
Why this is better: acceptability, appropriateness, and feasibility are distinct implementation outcomes (Proctor 2011). The Weiner scales measure them separately with validated items, so a reviewer can't accuse us of conflating "did residents like it" with "did it work." Adherence (objective backend data) and retention live under Feasibility above.
References. Weiner BJ, Lewis CC, Stanick C, et al. Psychometric assessment of three newly developed implementation outcome measures. Implement Sci. 2017;12:108. PMID 28851459.  ·  Proctor E, Silmere H, Raghavan R, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38(2):65–76. PMID 20957426.
Secondary Preliminary psychological — T0→T1 change by arm (Cohen's d)
MeasureConstructFormat
SCS-SFSelf-compassion (planned primary outcome of the future trial)12 items, 5-pt
MBI-GS (abbrev.)Burnout: exhaustion, cynicism, professional efficacyLikert frequency
PHQ-8Depressive symptoms8 items, 0–3
GAD-7Anxiety symptoms7 items, 0–3
Analysis is descriptive: feasibility/acceptability as percentages; psychological change as effect sizes (Cohen's d, 95% CI) via independent t-tests / ANCOVA (Mann-Whitney if non-normal). p-values exploratory only — no a priori power analysis (pilot).

Who's who

Johanna Lee, MD
PI & first author
MGH Anesthesia, Assistant PD. Owns IRB, MyCAP build, recruitment, analysis, and manuscript. Slavin grant PI.
Jimin Kim, MD
BWH site PI
Incoming BWH Anesthesiology PD (7/1/26). Advising + BWH recruitment; limited bandwidth for execution.
Dan Saddawi-Konefka, MD, MBA
Senior author / co-I
Mentor. Methodology, framing, writing, and air cover for resident recruitment via the APD team.
Ariel Mueller
ARC Director
MGH Anesthesia Research Center. Route to research coordinator + biostatistician (both Slavin-funded). Engage post-IRB.
Positive Intelligence, Inc.
Vendor
Provides the PQ platform free for this and future studies. Needs an executed Data Use Agreement (post-IRB).
Shirzad Chamine
External stakeholder
PQ creator. Not on protocol (kept independent). Milestone-only updates; Dan owns that channel.